HK Stock MarketDetailed Quotes

00241 ALI HEALTH

Watchlist
  • 2.610
  • -0.040-1.51%
Market Closed Apr 19 16:08 CST
42.00BMarket Cap47.45P/E (TTM)

ALI HEALTH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Sep 30, 2023
(FY)Mar 31, 2023
(Q6)Sep 30, 2022
(FY)Mar 31, 2022
(Q6)Sep 30, 2021
(FY)Mar 31, 2021
(Q6)Sep 30, 2020
(FY)Mar 31, 2020
(Q6)Sep 30, 2019
(FY)Mar 31, 2019
Turnover
12.66%12.96B
30.06%26.76B
22.90%11.5B
32.60%20.58B
30.66%9.36B
61.71%15.52B
73.97%7.16B
88.32%9.6B
119.13%4.12B
108.62%5.1B
Operating income
12.66%12.96B
30.06%26.76B
22.90%11.5B
32.60%20.58B
30.66%9.36B
61.71%15.52B
73.97%7.16B
88.32%9.6B
119.13%4.12B
108.62%5.1B
Cost of sales
-9.65%-10.09B
-27.88%-21.06B
-22.88%-9.2B
-38.39%-16.47B
-41.22%-7.49B
-61.59%-11.9B
-71.84%-5.3B
-95.64%-7.37B
-128.61%-3.09B
-110.34%-3.76B
Operating expenses
-9.65%-10.09B
-27.88%-21.06B
-22.88%-9.2B
-38.39%-16.47B
-41.22%-7.49B
-61.59%-11.9B
-71.84%-5.3B
-95.64%-7.37B
-128.61%-3.09B
-110.34%-3.76B
Gross profit
24.69%2.87B
38.79%5.7B
22.98%2.3B
13.57%4.11B
0.56%1.87B
62.11%3.62B
80.32%1.86B
67.61%2.23B
94.97%1.03B
103.92%1.33B
Selling expenses
-1.22%-869.38M
10.73%-1.77B
12.69%-858.89M
-62.13%-1.98B
-93.36%-983.71M
-69.08%-1.22B
-52.66%-508.74M
-58.90%-722.72M
-112.47%-333.25M
-126.18%-454.84M
Administrative expenses
2.20%-169.53M
3.95%-379.49M
-1.65%-173.34M
-34.57%-395.08M
-19.25%-170.53M
-33.47%-293.6M
-36.10%-143M
-21.52%-219.97M
-22.20%-105.08M
-49.29%-181.02M
Research and development expenses
1.44%-319.31M
7.00%-677.82M
-0.38%-323.99M
-72.04%-728.83M
-40.66%-322.75M
-67.55%-423.63M
-69.79%-229.45M
-15.44%-252.84M
-30.34%-135.14M
-73.52%-219.02M
Operating interest expense
27.04%-2.45M
-52.90%-5.83M
-356.17%-3.36M
-55.78%-3.82M
53.35%-737K
88.85%-2.45M
91.88%-1.58M
---21.97M
-322.44%-19.46M
----
Special items of operating profit
-32.71%-1.02B
-93.21%-2.33B
-28.23%-767.49M
2.43%-1.21B
2.55%-598.52M
-27.32%-1.24B
-50.05%-614.21M
-91.24%-970.75M
-64.65%-409.34M
-70.21%-507.61M
Operating profit
181.96%489.46M
360.82%539.61M
184.48%173.59M
-147.06%-206.89M
-156.55%-205.48M
919.41%439.63M
1,136.28%363.34M
238.14%43.13M
141.64%29.39M
70.01%-31.22M
Financing cost
----
----
----
----
----
----
----
----
----
---27.97M
Share of profits of associates
50.02%-9.78M
19.81%-37.6M
23.91%-19.57M
-74.59%-46.89M
22.56%-25.71M
-26.12%-26.86M
-80.30%-33.21M
-2,247.85%-21.3M
-13.21%-18.42M
-190.88%-907K
Share of profit from joint venture company
-92.04%1.59M
3,759.81%48.98M
1,401.28%19.95M
110.98%1.27M
123.34%1.33M
9.27%-11.56M
-6.55%-5.69M
-1,628.22%-12.74M
-166.34%-5.34M
-109.27%-737K
Earning before tax
176.63%481.27M
318.20%550.99M
175.69%173.98M
-162.94%-252.51M
-170.85%-229.86M
4,311.91%401.22M
5,664.77%324.44M
114.95%9.09M
107.14%5.63M
36.07%-60.83M
Tax
-245.19%-36.13M
-24.61%-16.73M
-513.48%-10.47M
77.06%-13.43M
96.28%-1.71M
-136.14%-58.54M
-246.13%-45.89M
19.86%-24.79M
-18.56%-13.26M
-122.72%-30.93M
After-tax profit from continuing operations
172.24%445.14M
300.90%534.26M
170.61%163.51M
-177.61%-265.94M
-183.13%-231.57M
2,283.23%342.68M
3,751.25%278.55M
82.90%-15.7M
91.52%-7.63M
15.84%-91.76M
Earning after tax
172.24%445.14M
300.90%534.26M
170.61%163.51M
-177.61%-265.94M
-183.13%-231.57M
2,283.23%342.68M
3,751.25%278.55M
82.90%-15.7M
91.52%-7.63M
15.84%-91.76M
Minority profit
-156.88%-748K
321.76%856K
547.78%1.32M
93.47%-386K
104.16%203K
35.15%-5.91M
25.28%-4.88M
7.18%-9.11M
-11.08%-6.53M
-376.46%-9.82M
Profit attributable to shareholders
174.91%445.89M
300.86%533.41M
169.98%162.19M
-176.18%-265.56M
-181.77%-231.77M
5,392.86%348.59M
25,819.69%283.43M
91.96%-6.59M
98.69%-1.1M
23.39%-81.95M
Basic earnings per share
175.00%0.033
300.51%0.0395
169.77%0.012
-174.90%-0.0197
-179.26%-0.0172
4,483.33%0.0263
21,800.00%0.0217
91.89%-0.0006
98.75%-0.0001
36.21%-0.0074
Diluted earnings per share
174.17%0.0329
300.00%0.0394
169.77%0.012
-175.19%-0.0197
-179.63%-0.0172
4,466.67%0.0262
21,700.00%0.0216
91.89%-0.0006
98.75%-0.0001
36.21%-0.0074
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young, Deloitte & Touche Tohmatsu
--
Ernst & Young, Deloitte & Touche Tohmatsu
--
Ernst & Young, Deloitte & Touche Tohmatsu
--
Ernst & Young, Deloitte & Touche Tohmatsu
(Q6)Sep 30, 2023(FY)Mar 31, 2023(Q6)Sep 30, 2022(FY)Mar 31, 2022(Q6)Sep 30, 2021(FY)Mar 31, 2021(Q6)Sep 30, 2020(FY)Mar 31, 2020(Q6)Sep 30, 2019(FY)Mar 31, 2019
Turnover 12.66%12.96B30.06%26.76B22.90%11.5B32.60%20.58B30.66%9.36B61.71%15.52B73.97%7.16B88.32%9.6B119.13%4.12B108.62%5.1B
Operating income 12.66%12.96B30.06%26.76B22.90%11.5B32.60%20.58B30.66%9.36B61.71%15.52B73.97%7.16B88.32%9.6B119.13%4.12B108.62%5.1B
Cost of sales -9.65%-10.09B-27.88%-21.06B-22.88%-9.2B-38.39%-16.47B-41.22%-7.49B-61.59%-11.9B-71.84%-5.3B-95.64%-7.37B-128.61%-3.09B-110.34%-3.76B
Operating expenses -9.65%-10.09B-27.88%-21.06B-22.88%-9.2B-38.39%-16.47B-41.22%-7.49B-61.59%-11.9B-71.84%-5.3B-95.64%-7.37B-128.61%-3.09B-110.34%-3.76B
Gross profit 24.69%2.87B38.79%5.7B22.98%2.3B13.57%4.11B0.56%1.87B62.11%3.62B80.32%1.86B67.61%2.23B94.97%1.03B103.92%1.33B
Selling expenses -1.22%-869.38M10.73%-1.77B12.69%-858.89M-62.13%-1.98B-93.36%-983.71M-69.08%-1.22B-52.66%-508.74M-58.90%-722.72M-112.47%-333.25M-126.18%-454.84M
Administrative expenses 2.20%-169.53M3.95%-379.49M-1.65%-173.34M-34.57%-395.08M-19.25%-170.53M-33.47%-293.6M-36.10%-143M-21.52%-219.97M-22.20%-105.08M-49.29%-181.02M
Research and development expenses 1.44%-319.31M7.00%-677.82M-0.38%-323.99M-72.04%-728.83M-40.66%-322.75M-67.55%-423.63M-69.79%-229.45M-15.44%-252.84M-30.34%-135.14M-73.52%-219.02M
Operating interest expense 27.04%-2.45M-52.90%-5.83M-356.17%-3.36M-55.78%-3.82M53.35%-737K88.85%-2.45M91.88%-1.58M---21.97M-322.44%-19.46M----
Special items of operating profit -32.71%-1.02B-93.21%-2.33B-28.23%-767.49M2.43%-1.21B2.55%-598.52M-27.32%-1.24B-50.05%-614.21M-91.24%-970.75M-64.65%-409.34M-70.21%-507.61M
Operating profit 181.96%489.46M360.82%539.61M184.48%173.59M-147.06%-206.89M-156.55%-205.48M919.41%439.63M1,136.28%363.34M238.14%43.13M141.64%29.39M70.01%-31.22M
Financing cost ---------------------------------------27.97M
Share of profits of associates 50.02%-9.78M19.81%-37.6M23.91%-19.57M-74.59%-46.89M22.56%-25.71M-26.12%-26.86M-80.30%-33.21M-2,247.85%-21.3M-13.21%-18.42M-190.88%-907K
Share of profit from joint venture company -92.04%1.59M3,759.81%48.98M1,401.28%19.95M110.98%1.27M123.34%1.33M9.27%-11.56M-6.55%-5.69M-1,628.22%-12.74M-166.34%-5.34M-109.27%-737K
Earning before tax 176.63%481.27M318.20%550.99M175.69%173.98M-162.94%-252.51M-170.85%-229.86M4,311.91%401.22M5,664.77%324.44M114.95%9.09M107.14%5.63M36.07%-60.83M
Tax -245.19%-36.13M-24.61%-16.73M-513.48%-10.47M77.06%-13.43M96.28%-1.71M-136.14%-58.54M-246.13%-45.89M19.86%-24.79M-18.56%-13.26M-122.72%-30.93M
After-tax profit from continuing operations 172.24%445.14M300.90%534.26M170.61%163.51M-177.61%-265.94M-183.13%-231.57M2,283.23%342.68M3,751.25%278.55M82.90%-15.7M91.52%-7.63M15.84%-91.76M
Earning after tax 172.24%445.14M300.90%534.26M170.61%163.51M-177.61%-265.94M-183.13%-231.57M2,283.23%342.68M3,751.25%278.55M82.90%-15.7M91.52%-7.63M15.84%-91.76M
Minority profit -156.88%-748K321.76%856K547.78%1.32M93.47%-386K104.16%203K35.15%-5.91M25.28%-4.88M7.18%-9.11M-11.08%-6.53M-376.46%-9.82M
Profit attributable to shareholders 174.91%445.89M300.86%533.41M169.98%162.19M-176.18%-265.56M-181.77%-231.77M5,392.86%348.59M25,819.69%283.43M91.96%-6.59M98.69%-1.1M23.39%-81.95M
Basic earnings per share 175.00%0.033300.51%0.0395169.77%0.012-174.90%-0.0197-179.26%-0.01724,483.33%0.026321,800.00%0.021791.89%-0.000698.75%-0.000136.21%-0.0074
Diluted earnings per share 174.17%0.0329300.00%0.0394169.77%0.012-175.19%-0.0197-179.63%-0.01724,466.67%0.026221,700.00%0.021691.89%-0.000698.75%-0.000136.21%-0.0074
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young, Deloitte & Touche Tohmatsu--Ernst & Young, Deloitte & Touche Tohmatsu--Ernst & Young, Deloitte & Touche Tohmatsu--Ernst & Young, Deloitte & Touche Tohmatsu

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg